NAMPT and Impaired glucose tolerance: Concordantly, Dogru et al. [100] found higher visfatin levels in diabetic patients than controls, without differences between non-obese patients with newly diagnosed diabetes and newly diagnosed impaired glucose tolerance (IGT), as well as between patients with IGT and healthy controls.